Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Schizophr Res. 2020 May 28;222:274–282. doi: 10.1016/j.schres.2020.05.035

Table 1.

Participant characteristics at admission of the overall sample by course of cannabis use (N = 938).

Course of cannabis use
Group comparisons
Overall (N = 938)
Group 1: no use (N = 475)
Group 2: reduced (N = 155)
Group 3: persistent (N = 308)
Overall difference
Pairwise: 1 vs 2
Pairwise: 1 vs 3
Pairwise: 2 vs 3
Measures N %, M (SD), Med (IQR) N %, M (SD), Med (IQR) N %, M (SD), Med (IQR) N %, M (SD), Med (IQR) Test Statistic p p p p
Demographic measures
Age (years) 938 21.0 (3.3) 475 21.1 (3.5) 155 21.0 (2.9) 308 20.9 (2.9) F(2, 935) = 0.39 0.676
Gender χ2(4) = 21.72 <0.001 0.014 <0.001 0.839
 Female 236 25.2% 150 31.6% 30 19.4% 56 18.2%
 Male 697 74.3% 322 67.8% 124 80.0% 251 81.5%
 Other 5 0.5% 3 0.6% 1 0.6% 1 0.3%
Race χ2(6) = 24.39 <0.001 0.006 0.001 0.916
 White (non-Hispanic) 253 27.0% 116 24.4% 46 29.7% 91 29.5%
 Black (non-Hispanic) 335 35.7% 158 33.3% 62 40.0% 115 37.3%
 Hispanic 258 27.5% 133 28.0% 40 25.8% 85 27.6%
 Other 92 9.8% 68 14.3% 7 4.5% 17 5.5%
Insurance status χ2(6) = 7.13 0.309
 Uninsured 48 5.1% 30 6.3% 7 4.5% 11 3.6%
 Public 430 45.8% 214 45.1% 71 45.8% 145 47.1%
 Private 383 40.8% 190 40.0% 70 45.2% 123 39.9%
 Other 77 8.2% 41 8.6% 7 4.5% 29 9.4%
Social/family measures
Homelessness χ2(2) = 4.99 0.083
 No 885 94.3% 456 96.0% 143 92.3% 286 92.9%
 Yes 53 5.7% 19 4.0% 12 7.7% 22 7.1%
Lives with family χ2(6) = 7.63 0.267
 Parents 787 83.9% 408 85.9% 132 85.2% 247 80.2%
 Other family (not parents) 63 6.7% 28 5.9% 8 5.2% 27 8.8%
 Alone 41 4.4% 15 3.2% 7 4.5% 19 6.2%
 Other 47 5.0% 24 5.1% 8 5.2% 15 4.9%
Family contact χ2(4) = 2.26 0.688
 Daily 842 90.8% 430 90.9% 141 91.6% 271 90.3%
 Weekly 60 6.5% 31 6.6% 7 4.5% 22 7.3%
 Monthly or less 25 2.7% 12 2.5% 6 3.9% 7 2.3%
Legal issues χ2(2) = 7.68 0.021 0.287 0.006 0.223
 No 454 88.7% 233 92.1% 93 88.6% 128 83.1%
 Yes 58 11.3% 20 7.9% 12 11.4% 26 16.9%
Clinical measures
Time to OTNY (days) 937 170.0 (82.0–341.0) 474 175.5 (85.0–337.0) 155 149.0 (75.0–286.0) 308 180.0 (85.5–351.0) χ2(2) = 1.78 0.412
Age at onset of psychosis 937 20.9 (3.2) 474 21.0 (3.5) 155 20.9 (2.9) 308 20.8 (2.9) F(2, 934) = 0.39 0.680
Violent ideation/attempt χ2(2) = 8.17 0.017 0.053 0.008 0.851
 No 722 77.0% 384 80.8% 114 73.5% 224 72.7%
 Yes 216 23.0% 91 19.2% 41 26.5% 84 27.3%
Suicide ideation/attempt χ2(2) = 6.19 0.045 0.079 0.024 0.964
 No 669 71.3% 356 74.9% 105 67.7% 208 67.5%
 Yes 269 28.7% 119 25.1% 50 32.3% 100
Baseline tobacco use χ2(2) = 56.37 <0.001 <0.001 <0.001 0.079
 No 802 85.5% 445 93.7% 127 81.9% 230 74.7%
 Yes 136 14.5% 30 6.3% 28 18.1% 78 25.3%
Baseline alcohol use χ2(2) = 87.04 <0.001 <0.001 <0.001 0.012
 No 703 74.9% 415 87.4% 84 54.2% 204 66.2%
 Yes 235 25.1% 60 12.6% 71 45.8% 104 33.8%
Baseline other drug use χ2(2) = 44.85 <0.001 <0.001 <0.001 0.073
 No 884 94.2% 470 98.9% 133 85.8% 281 91.2%
 Yes 54 5.8% 5 1.1% 22 14.2% 27 8.8%
Baseline outcome measures
GAF symptoms 937 30.7 (14.9) 474 32.5 (15.9) 155 29.7 (13.1) 308 28.3 (13.7) F(2, 934) = 7.81 <0.001 0.053 <0.001 0.282
GAF SF 934 56.3 (15.9) 472 56.9 (16.0) 155 55.9 (14.9) 307 55.7 (16.4) F(2, 931) = 0.60 0.548
GAF OC 933 36.2 (20.0) 472 37.9 (21.4) 155 35.3 (18.3) 306 34.1 (18.3) F(2, 930) = 3.62 0.027 0.170 0.010 0.510
Education/employment χ2(2) = 1.45 0.483
 No 553 59.0% 271 57.1% 95 61.3% 187 60.7%
 Yes 385 41.0% 204 42.9% 60 38.7% 121 39.3%
Any psychiatric hospitalization χ2(2) = 5.34 0.069
 No 244 26.0% 136 28.6% 30 19.4% 78 25.3%
 Yes 694 74.0% 339 71.4% 125 80.6% 230 74.7%
Medication adherence χ2(6) = 14.54 0.024 0.003 0.391 0.167
 Not med adherent 139 14.8% 56 11.8% 36 23.2% 47 15.3%
 Med adherent 651 69.4% 346 72.8% 96 61.9% 209 67.9%
 Not prescribed meds 61 6.5% 27 5.7% 12 7.7% 22 7.1%
 Missing 87 9.3% 46 9.7% 11 7.1% 30 9.7%
Early discharge prior to χ2(2) = 0.404
 1 year No 634 67.6% 328 69.1% 98 63.2% 208 67.5%
 Yes 304 32.4% 147 30.9% 57 36.8% 100 32.5%